<SEC-DOCUMENT>0001437749-11-008657.txt : 20111115
<SEC-HEADER>0001437749-11-008657.hdr.sgml : 20111115
<ACCEPTANCE-DATETIME>20111115082411
ACCESSION NUMBER:		0001437749-11-008657
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20111114
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20111115
DATE AS OF CHANGE:		20111115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		111205637

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bkyi_8k-111411.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
    <title>bkyi_8k-111411.htm</title>
    <!--Licensed to: Beby33111-->
    <!--Document Created using EDGARizerAgent 5.4.2.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<br>
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt">Washington, D.C. 20549</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 8-K</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">CURRENT REPORT</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date of Report (Date of earliest event reported): November 14, 2011</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">BIO-key International, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or other jurisdiction of </font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">incorporation)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1-13463</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Commission File Number)</font></div>
</td>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">41-1741861</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S. Employer Identification No.)</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3349 Highway 138, Building D, Suite B</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Wall, NJ 07719</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(732)&#160;359-1100</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="FONT-STYLE: italic; DISPLAY: inline">see</font> General Instruction A.2 below):</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o </font>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o </font>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o </font>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: wingdings">o </font>Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div>&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="10%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Item 2.02.&#160;</font></font></td>
<td width="90%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Results of Operations and Financial Condition.</font></font></td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 14, 2011, BIO-key International, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for its third quarter ended September 30, 2011 which is included as an exhibit to a Current Report on Form 8-K.&#160;A copy of the press release issued by the Company on November 14, 2011 is attached as Exhibit&#160;99.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="10%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Item 9.01.</font></font></td>
<td width="90%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial Statements, Pro Forma Financial Information and Exhibit.</font></font></td>
</tr></table>
</div>

<div>&#160;</div>
</div>

<div align="center">
<table align="center" bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(d)&#160;</font></td>
<td width="95%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Exhibits</font></td>
</tr></table>

<div>&#160;</div>

<table align="center" bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="5%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99.1&#160;&#160;&#160;</font></td>
<td width="95%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Press Release, dated November 14, 2011, issued by <font style="DISPLAY: inline; FONT-FAMILY: times new roman">the Company.</font></font></td>
</tr></table>
</div>

<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">BIO-KEY INTERNATIONAL, INC.</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date: November 15, 2011</font></font></td>
<td colspan="2" valign="top" width="38%">&#160;</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/&#160;Cecilia C. Welch</font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%">

<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cecilia C. Welch</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%">

<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Financial Officer</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>
</div>

<div>&#160;</div>

<div align="center">
<table align="center" bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="13%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit No.</font></font></font></td>
<td width="87%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></font></td>
</tr></table>

<div>&#160;</div>

<table align="center" bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="13%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99.1</font></font></td>
<td width="87%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Press Release, dated <font style="DISPLAY: inline; FONT-FAMILY: times new roman">November 14, 2011, issued by </font>the Company.</font></font></td>
</tr></table>
</div>

<div>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
    <title>ex99-1.htm</title>
    <!--Licensed to: RDG Filings-->
    <!--Document Created using EDGARizerAgent 5.4.2.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">


<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">Exhibit 99.1</font></div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%">
<div><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div><img src="ex99-16.jpg" alt=""></div>

<div>&#160;</div>
</td>
<td valign="bottom" width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font>
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold">NEWS RELEASE</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold"><font size="2">Contacts:<font id="TAB1" style="MARGIN-LEFT: 18pt"></font><font style="DISPLAY: inline; TEXT-DECORATION: underline">BIO-key International, Inc.</font></font></font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160; Scott Mahnken</font></font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">732-359-1113</font></font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">BIO-key&#174; International, Inc. Reports</font></div>

<div align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">2011 Third Quarter Financial Results</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Wall, NJ, November 14, 2011</font> &#8211; BIO-key International, Inc. (OTCBB: BKYI.OB), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported financial results for the third quarter ended September 30, 2011.&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total revenue for the three months ended September 30, 2011 was approximately $574,000, representing an increase of 5% from the $546,000 reported for the quarter ended September 30, 2010. The increase was primarily related to service revenues for maintenance and support contracts, which were driven by a mix of new accounts and renewed maintenance agreements from legacy customers. The increase was offset by a decrease of in its core license revenue.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key&#8217;s gross margin for the third quarter of 2011 was 63%, compared to 62% for the same period in 2010, due to similar costs related to the associated revenue. Operating expenses for the third quarter of 2011 decreased 17% to approximately $897,000, compared to $1,083,000 for the same period ended September 30, 2010.&#160;Operating loss for the third quarter of 2011 was ($533,970), compared to operating loss of ($742,824) reported in the quarter ended September 30, 2010.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The net loss for the three months ended September 30, 2011 was ($540,165) compared to net loss of ($943,790) for the comparable period in 2010.&#160;&#160;Net loss for the 2010 period included approximately ($45,000) in expenses related to derivative and fair value adjustments that are no longer applicable in 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Although the summer months are usually the slowest period of the year for BIO-key we increased revenue by 5% quarter-over-quarter while continuing to reduce expenses and increase productivity,&#8221; stated Mike DePasquale, CEO, BIO-key International, Inc.&#160;&#160;&#8220;As previously announced, we also executed a Letter of Intent to purchase S.I.C. Biometrics which is a cutting edge mobile identification technology company. During the past few quarters, I have mentioned BIO-key&#8217;s commitment to providing a best in class mobile identification solution for healthcare, government agencies, and the commercial enterprise including consumers.&#160;&#160;Our software is already available for those markets on the most popular devices and we believe that the pending acquisition of S.I.C Biometrics will empower us to deliver a complete offering for the Apple mobile platform,&#8221; added DePasquale.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Oracle recently stated in a survey released on November 1, 2011 of more than 3,000 mobile phone subscribers worldwide, that 68 percent were either unsure or convinced that data stored or transmitted by their mobile phones was unsecure.&#160;&#160;As a result, only 21 percent of respondents said they would be &#8220;very comfortable&#8221; making a purchase with their mobile phone instead of a credit card or cash.&#160;&#160;In a separate study conducted by the Lieberman Research Group and published by Unisys in September 2011, over one thousand consumers were surveyed about security and the financial system.&#160;&#160;The survey reported that 57% were willing to provide fingerprint biometric data as a way to secure their financial transactions.&#160;&#160;&#8220;BIO-key&#8217;s universal software security offering for mobility platforms including Android, Apple iOS and WinMobile put us in a first mover position for secure enterprise access anywhere, anyplace, anytime. From a single fingerprint enrollment and from any device, desktop, laptop or mobile handset, users can access authorized accounts or information with a single swipe of the finger&#8221; stated DePasquale.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;To further enhance our commitment to mobility and to expand the BIO-key brand recognition globally, we have engaged with the leading independent public relations firm Edelman and are currently developing a national and international messaging and media plan which will launch in 2012,&#8221; said Scott Mahnken, BIO-key&#8217;s VP Marketing.&#160;&#160;&#8220;We also launched our new company website and social media campaign including Facebook, Twitter, LinkedIn and YouTube, which already hosts several of the product demonstration videos, including the new solutions for the iPad and iPhone,&#8221; explained Mahnken</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Nine Month Comparisons</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Total revenue for the nine months ended September 30, 2011 was $2.963 million representing less than 1% increase from the $2.955 million reported for the same period in 2010.&#160;&#160;Although the revenue amounts are similar, the product mix varied with an increase in third party hardware revenue to approximately $778,000, license revenue of $1.6 million and service revenue of $538,000 for the nine months ended September 30, 2011, compared with third party hardware revenue of approximately $427,000, license revenue of $2.1 million and service revenue of $316,000 for the same period in 2010.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Gross margin for the nine months ended September 30, 2011 was approximately $2.3 million representing an 8% decrease from the same period in 2010 of $2.5 million. Operating expenses for the first nine months of 2011 decreased 13% to approximately $2,829,000, compared to $3,240,000 in the comparable period ended September 30, 2010.&#160;The decline in operating expenses were primarily related to lower legal, accounting and referral fee expenses, offset by an increase in R&amp;D expenses. Operating loss for the nine months ended September 30, 2011 was ($484,021) compared to an operating loss of ($704,926) reported for the same period in 2010.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Net loss for the first nine months of 2011 was ($894,319) compared to net income of $291,534 for the same period in 2010.&#160;&#160;Net income for the 2010 period included approximately $933,000 in income related to derivative and fair value adjustments and $414,176 in income from discontinued operations, both no longer applicable in 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Liquidity and Capital Resources</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Consolidated cash, cash equivalents and accounts receivables totaled over $1.2 million on September 30, 2011, compared to $1.4 million as of December 31, 2010.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Highlights for the third quarter included the following:&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Purchase orders from the Indiana Blood Center, Allscripts, NextGenID, BIOXS, CACI, Nationwide Children&#8217;s Hospital, Medflow, ChoicePoint / LexisNexis, Educational Biometric Technology, Identimetrics and Genesis Healthcare.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Announced the pending acquisition of S.I.C. Biometrics, a hardware and software developer located in Montreal, Canada.&#160;&#160;S.I.C. is recognized for developing the first fingerprint identification technology solutions for the Apple iPad and iPhone.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Announced partnership with AuthenTec to combine efforts to identify mobile identification solutions for the Android and other mobile platforms.&#160;&#160;AuthenTec is a leading fingerprint device manufacturer.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Engaged in an agreement with the Edelman public relations agency to promote the BIO-key name and brand globally to strategic target markets.&#160;&#160;Edelman is the largest independent global public relations firm and BIO-key is working with their client development team in Washington D.C.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Presented BIO-key mobile identification solutions and core technology at the Allscripts Client Event Expo in August.&#160;&#160;The ACE event is the largest annual gathering of Allscripts vendors and sales representatives.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Attended the Biometric Consortium Conference in September.&#160;&#160;The BCC is a networking conference focused on biometric technologies for Defense, Homeland Security, Identity Management, Border Crossing and Electronic Commerce.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Launched the new <font style="DISPLAY: inline; FONT-WEIGHT: bold">www.bio-key.com</font> website.&#160;&#160;The website launch included the introduction of BIO-key&#8217;s new social media program including Facebook, Twitter, LinkedIn and YouTube.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top" style="LINE-HEIGHT: 1.25;">
<td style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 18pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#9679;</font></font></font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Introduced our updated WEB-key release to integrate with Android, Apple iOS and WinMobile platforms.</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Conference Call Details</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key has scheduled a call for Tuesday November 15<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">th</font>, at 10:00 a.m. Eastern Time to discuss 2011 third quarter results.&#160; To access the conference call live, dial 800-860-2442 (U.S.) or 412-858-4600 (International) and ask for the BIO-key call at least 10 minutes prior to the start time.&#160; The conference call will also be broadcast live over the Internet by logging onto <font style="DISPLAY: inline; FONT-WEIGHT: bold">www.bio-key.com</font>. A telephonic replay of the conference call will be available through December 15, 2011 and may be accessed by dialing 412-317-0088&#160;and using the pass code 10006712#. A streaming audio replay of the webcast will be available shortly after the call on the Company&#8217;s website (www.bio-key.com) for a period of thirty days.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About BIO-key</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers.&#160;BIO-key&#8217;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#8217;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.&#160;&#160;BIO-key&#8217;s technology is offered directly or by market leading partners around the world. (<font style="DISPLAY: inline; FONT-WEIGHT: bold">http://www.bio-key.com</font>)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">BIO-key Safe Harbor Statement</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain statements contained in this press release may be construed as &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8221;).&#160; The words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intends,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes&#8221; and similar expressions are intended to identify forward-looking statements.&#160; Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#8220;safe-harbor&#8221; provisions of the Act.&#160; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.&#160; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel and our ability to complete the proposed acquisition of S.I.C. Biometrics Inc. as currently planned.&#160; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2010 and its other filings with the Securities and Exchange Commission.&#160; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&#160; The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.</font></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-16.jpg
<TEXT>
begin 644 ex99-16.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`0$!
M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H*
M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`*D`
MX0,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/W[WCT-&\>AIE%`#]X]#1O'H:910`_>/0T;QZ&HWD5!N./H37SK
M^UO_`,%1?V1_V-[6:T^)7Q$M[S6T4^5X=T5A<79;T95XC_X$16-?$T,+3YZL
ME%>9V8'+\=F6)5#"4I5)O913;_`^BVN%4X(-5=8\1Z'X>T^35M>U6WLK:)<R
MW%W.L:(/4LQ`%?B;^T[_`,''/[17Q"DN-&_9Q\%:?X,L'RL>J7R"[OBO9@#^
M[0_@U?#/Q?\`VG/VB?C]J+:G\9OC5XD\1NS;A'J>JR/$A_V(LA$'LJBOD<;Q
MKE]%\M"+F_N7^?X'[!DG@;Q+CXJICJD:$7T^*7W+1?>?T0_%/_@JK^P#\'VD
M@\7?M+^'9;B+.^UTFY-Z^?3]P&`/U(KP7QO_`,'&?[!V@.\/ANP\6:TZY"M;
MZ0(T;\7;/Z5^#QR3SG)-;'@_X>?$#XAWG]G^`?`VL:W-D`QZ3ILMP03Z[%./
MQKYZKQMFM:7+2@E\FV?HN%\#N$L'3YL;7G+S<HQ7X+]3]@]3_P"#F[X#V\^W
M2_V=_$\\><;GU"!#^50#_@YV^#8X_P"&:_$G_@U@_P`*_/3P-_P2>_X*&?$&
M!+O1/V7_`!!##(H99=16.W!!]G8$?E7I>A?\$!O^"C>LJ&G\`:)8Y[7>OQ@C
MZX!JJ>;\7UE>$'_X`O\`(RK\'>"V#?+5K037_3]_I(^WO"__``<P_LLW\XC\
M3?!WQ=IRG[TD7DSX_`$5['\.O^"\_P#P3E\=M';W_P`4K_0)7P`NN:/+&N?]
MY`PK\T[O_@WC_P""A=M;-.FE^%96`XB37QD_FM<9XI_X(=_\%)/"Z&3_`(4;
M'J*C/_(+U>&4\>Q(KJAG7%V'5YT'+UC_`)'D5N"?!K&MJAF"IORJI_\`I29^
M]7PK_:K_`&<?C?&C_"7XU^&M?+KD0Z=J\3RCZQ[MP_$5WJW$;'"FOY>_''[%
M_P"VC\$)QJOBOX`^-=%:W;<+VWTN4B,C^(20YV_7->A_L]_\%=OV^?V9KZ/3
MM.^,^H:]I]NP630_&):]3:/X0TA\V/TX8`>E=]#C/V<E'&T7'S7^3_S/#QW@
ME/$TW5R3'TZRZ)__`"4;K\$?TA"13R*7>/0U^:W[(W_!Q=\!?B=):^%/VDO"
MLW@?4Y2J?VK`YN-/9CQDD#?&,^H.*_0SP3X^\(?$3PY:^+?`_B>PUC3+R,/;
M7VG7*RQ2#V9217UF"S+`YA#FP\U+\_N/R+.^&L]X<K>RS&A*F^C:]U^DEH_O
M-W>/0T;QZ&F=:*[CPQ^\>AHWCT-,HH`?O'H:-X]#3**`'[QZ&C>/0TRB@!^\
M>AH#!NE,IT?>@!U%%%`$=%%(QVJ6]!0`M>?_`+1'[3GP9_9;\`W/Q'^-'C:S
MT?3K<'9YS_O;A@/N1I]YV/H*\F_X*)_\%+OA'^P+X`-]KTB:MXJU"%O[`\,P
MR@23MCB20]4B!ZMWZ#)K\"_VK/VO_CI^V5\2[CXF_&WQ?+>SNQ%CIT+%+2PB
MSQ%#%G"@>O5NI)-?+Y[Q+A\J7LJ?O5.W1>O^1^H\`^&.9<7S6*KOV6%7VNLO
M*"_!RV7F?7'[?/\`P7P^/'[0-U>?#_\`9JEN/`OA-BT4FI0D?VI?ITYD_P"6
M"GT3YO5NU?G]J.I:AJ][+J6JWTUU<3N7FGN)2[NQZDL3DGWJ&OJ?]@#_`().
M?M$?MTZK%KMA9MX9\%QN/MGBG4H#MD7/*V\?!F;'?A1W-?FDZV:9[BU%MSF^
MG1?HD?U%A\%PAX>Y.YQ4:%*.\G\4GYO>3\ON1\R^'?#GB#Q=K5OX;\*Z)=ZE
MJ%V^RULK&W:665O154$FONK]DS_@W]_:N^.2VOB/XRW5M\/]#FVNRWR^=?NG
M7Y85("G']YA7ZQ_L7_\`!-G]EW]B;P[':?"_P/'=:V8PM]XHU9%FOKEL<G?C
M$:^BH`![]:]_$,8&`*^VRW@JE!*>,ES/LMOF^I^&<4>.>88F4J.24_9P_GDK
MR?FH[+YW?H?&7[/'_!"']@/X(Q0ZCXB^'\_CC58U!:\\67!FBW>JVZXB`_WE
M;ZU]9^$OAC\/?`.GII/@CP5I6D6L:@);Z;81P(H'3`0"MT``8%%?98;`X/"1
M4:--1]$?B>99YG&<U74QV(G4?]Z3:^2V7R$5%1=H[4N!G..:**ZSRPI&4,,4
MM!..30%T0W5E;W:&.>)'4C!5U!!_.O*OC5^PC^R)^T/926?Q@^`/AO6'D4C[
M8^G+%<I[K-'MD4^X:O5WN8UZ,/Q-(+N'.#(#]#6-6E1JQY:D4UYJYOAL5B<)
M452A4<7WBVG^!^7/[47_``;7_"[6HKG7?V4_B=?:#=89H="\1.;FU8]=JS#]
MX@[?-O\`K7QEI%[_`,%./^"-GQ#%[+8ZGINC-.!/;3$WFB:DN>^/E1CV8;7'
MZ5_0J'CD'0'-97C/P!X-^(7AZY\*>-O"]CJVG7<1CN;'4+998Y5/!!5LBOG,
M7PM@YS]MA&Z51;-;?-'Z5E'BIG5+#O!9Q".+P\MXS2<K>4N_^*_DT?,'_!/'
M_@KC\"/VZ=+A\,R2Q^&?&\<(-WX;OK@?OB!R]NYQYJ]\?>'<5]:I(L@)4]*_
M*+]O'_@@O?\`@[4Y/V@_^">VLWFC:M82_;#X02]93&ZG=NLIB=R'/2-CCT(Z
M5Z5_P2I_X*\:I\7M33]D_P#;`3^P_B3I3?9+?4+V+[/_`&LR<%)$.!'<#'(&
M`_4`=*TP6:XNAB%A,Q5IOX9+X9?Y/R.;/.%LHS#`RS?AJ;G1CK4I/^)2]?YH
M>:O\]S]%:*9%*).5.1ZT^OI3\W04444`%%%%`!3H^]-IT?>@!U%%%`$9QCFO
MG?\`X*-_M^^`OV"/@K<^-M96*^\0Z@C0>&=#:3!N[C'#-CD1KU8^G'4U[3\4
M/B1X1^$?@+5OB/X\U5+'2-%L)+O4+J0\1QHI)^IXP!W/%?S7_M^_MI>-OVY?
MVA]5^+?B*6:#2DF>W\,:0\F5L;%6.Q<=/,8?,Y[L3C@"OF^(\[64X6U/^)+;
MR\S]*\-.!I\8YOS5TUAZ5G-]WTBO7KV7JC@OCO\`'7XF_M(_%'5/B_\`%SQ+
M-JFM:M.7FFD;Y8U_ABC7HB*.`HX`KC\49QWK]`/^")G_``2Z?]J[QK_PT/\`
M&71R/`7AZ]VV%G.G&M7J8.W'>%#C<>YPOKC\KP>$Q6;XU4XZREJV_P`6S^M\
M\SC*.#<@EB:J4*5-6C%6U>T8I=W_`)LZ;_@D3_P1=O/CV++]I#]J;2KBS\(H
MZS:#X8D4I+K&.1+-GE(/1>K^H`Y_:3PMX7\.^#]$MO#?A;1+?3K"S@$5K9VD
M(CCB0`8"J!@"K.F:98Z5I\.FV%I'#!!&L<442!510,``#H!5FOV3*LIPN58=
M0I+7J^K/XGXMXOS;C#,GB<7*T5\$%\,5Y=WW;U8`!1@"BBBO4/E@HHHH`*R_
M%OC/POX$T.Y\2^,->M-,T^TC+W%Y>SK''&H[EF.!7-_M"?'OX<?LV_"C5_C#
M\4M:6QT?1[8RSN3\\C?PQH/XG8\`>M?@!^W?_P`%)?VB/^"BWQ2_X1[3?M]A
MX6DO1!X:\%:8S-YF3A&EV\S3-U/89P!Z^%G.>X?*::3UF]H_Y]D?=\$\!YEQ
MEB9.#]G0A\=1[+R7=V]$NK/T9_:Z_P"#BK]GOX1WUSX1_9S\)3_$#5H<J=2:
MX-KID;YQ]_!>;'^R`#_>%?&.H?\`!5?_`(*]_MG^(9-%^"$FHV<4KD+I_@/P
M^56,$\`S,'?\2XKW[_@G/_P;XZ;<:98_%S]MR222><+-9>!+20JL*]0;N0<L
MQ_YYKP.Y/0?J5\,_A+\./A!X=B\)_#7P1IFAZ?`H6.UTVS2)<#@9VCGZFO'H
M8/B'-X\^*K.E![1CH[?I\V?8XW//#C@^3PV4X-8RM'1U:NL+KLMG\DEYL_&S
MPM_P3<_X+C_&Z)=5\;?%[6-%$H#8\0^.Y589]4B+D'VQ7=:)_P`$=O\`@L5X
M10:AX9_;?LH+E1GRX_%^I#]3%BOU]P,8VC\J*]"'"^!CK*<V^_,SY^MXJ9_4
M]V%##PC_`"JC&WXW/RMT6T_X.(OV50-0N)=%^*.EVV&EL;F>&\>11U`8>5/G
MZ$_2O8?V>/\`@M_X!U?Q5!\*/VS/A)K/P?\`%,D@B5]:B<Z=-)TXE95:/)_O
M#'^T:^\"H(P17#_&S]G+X+?M$>&9_!_QA^'&E:[8SQE&2_M%9UR.JOC<I]P1
M73'+,9@[?5:[=ND_>7I?='E5N)\GS?W<SP$(M_;H+V<EY\NL)>C2]4=7I>JZ
M1XBTR+5=)OH;JVGC$D-Q;RAT=3R"K#@BOC/_`(*B?\$I?"W[6VCO\:/@J4\.
M?%30T$^FZI9D1#4F3YEBE*_QY'RR=5/7BL:'X>_&C_@DKKG_``D7@K6M7\;_
M`+/UQ.!K&AWDC7&I>#E8X^T0MR9K9?XEZJ.>:^V_!WBOPYX]\+6/C'PIJL-_
MI>J6J7-A>V\@:.>)U#*ZD=00:W<:&9T)8?$1M);KMV<7^J/.I5<=POCJ68Y;
M6YH._+)+1KK"<>CMO%Z-:IM:GR)_P22_X*`>(?VA_"=]^SG^T/:OI/Q9\`$V
M>O6=XOER:C$AVK<!3_&.%<#C.&'#`#[3KX"_X*G?LP>+/A)X_P!'_P""FG[,
MNFM'XO\`!4D;^,--LUP-:TM<"0N!]YU3()[K_NBOLG]GSXS^#_VA?@[X=^,O
M@6\$^F>(-+CN[=@>5+#YD;T96RI'8BEEU6O2D\)B)7E'9_S1Z/U6S-.(L+@L
M1"&;8"/+2JZ2A_S[JK64?\+^*'EIT.THHHKUCY4****`"G1]Z;3H^]`#J***
M`/RB_P"#CC]L^Z\/>'-&_8[\&:L5GUB-=3\3F)\8MU8B&$X_O,"V/]D5^/E>
ML?MQ_M!:C^U#^U=XW^,UY<M);ZEKDR:4K$_N[*)C'`H]/D53]6->3D]S7X;G
MF82S+,IU?L[+T7]7/[PX`X=APQPO0PCC:;7--]7.6K^[;Y'IG['_`.S7XJ_:
MW_:&\.?`SPHC*^K7H^W70&1:VJ_-+*?3"@X]\5_2A\-/"OP:_93^#^B_#K3=
M4TGP]H&@Z<EO;&\NXX$VJ/F<EB`23DD^I-?E+_P1N_9@^/GAC]B3XM_M?_LZ
M>&[*]^)^L:7<Z3\+H=4*I$TD('F/N<A1ND^0$D#,9SQ7X(_MM_M%?MR_$KXV
M>(_"G[9_Q2\67WBG1]8GM-:T76M4=H[&Y1RKQ")6\M=I!'RC%?H?!^61PF`^
ML27O3_\`2>GW[G\X^,W%-7..(WEU.7[K#Z6Z.?VG\OA7S[G]A_B7_@J-_P`$
MYO!^H/I7B?\`;=^%]E<QG$D$_C2S#*?0CS,UW?P@_:G_`&;/C_";CX)?'CPE
MXK51D_V!K]O=$?A&Y-?SG?\`!-K_`(-.O'?[<7[)GAO]J7X@_M/VWA"/QAIX
MOM!T:ST(W;K;L3Y;RN9%&6`SM`X!ZU\G?\%'_P#@G3^V)_P0K_:9T.TC^*5Q
M$NJ0-?>#?'/A>YEM3=I&X#HP#;HY$)7<A)&&!R0:^O/QT_L=FN;>VA:YN)TC
MC12SR.P`4#J23T%<R?CE\%E)5OBYX9!!P0=<M_\`XNOR\_X(<?\`!1KQ/_P6
MX_8#^)?[(7[0_C*\T_Q[I6@-HVL>)-'D$-U<V%Y$\45ZA'"S`JZMCJ0#WK\(
M/^"O_P"P???\$QOVS]7_`&7;'XMWOBF"TTZUOK;59XS!(R3J6"NH8C(QU'6@
M#^RW0?BI\,O%-_\`V5X9^(>B:A=%2PMK+5(I9,#J=JL36]7\[?\`P:H?\$D5
M^,,^@_\`!3O7/CUK-BWA7Q1=V-AX4TX%4O&CA"L9Y"V6C/F_<`YVC)K[S_X+
M[?\`!>GPW_P3`\(P?!3X*_8M9^+OB"Q,MK;S_/!H=L<JMS.O\3D@[$/7!)X%
M`'MO_!93]D?5_P!L']G.U\'>&_C!HGA>\T?4QJ$:>(-0^SV=]A"ICD?G;C.0
M<$`U\=?\$KO@;_P3X_8M^(;?$3]JG]MWX,ZC\0P3%HFB67C:UFATH9P7W.R[
MIF]<`*.F3S7XV_L^_!W_`(*M_P#!>O\`:`O]&TGX@>(O%D_F_:->UKQ!K$L6
MCZ/&YX+`?(GHL:*6..!U-?<FK_\`!E!^TU;^"?M^B_MB^#[G7Q$6_LZ;0;B*
MV9\?=\X.S#G^+9^%>75R?`UL>L9.-YK[ON/J<+QEG^"X=GDE&HHT)MMV24M=
MUS;V>EU^)_0[X(^(?P_^(NCIKOP^\:Z5K=E(N4N]*OX[B,C_`'D)%;5?QF>*
MHO\`@J-_P09_:A'@G4_$WB'P!K]D5NK6.TU!IM*UJVW$"5`"8KB)L$'C<"""
M%(Q7]'/_``0D_P""UW@G_@K%\&;S2O%5M:Z)\4O",$0\5Z#$V$NH6X2^MP>3
M&S`JR]4;`/#*3ZB/EC[ZHHHH`1G1?O.!]37,6GQN^#E_X_/PIL?BEX?F\3"!
MICH$6KPM>",=6\H-NP/7%?`/_!R;X<_X*;2_LFW'Q"_81^*$?AWPMX4T34=5
M^)RV6H+::C)8P0^8SPR$9*JBR$HI#''&3Q7X6?\`!N-XR\6Z]_P6_P#A#K6N
M>)KZ^O-1U+4Q?WEY=/)+<@Z;=$[W8DMD@'GN*`/Z\-6TRQU;3YM/U&TCGMYX
MFCG@F0,DB$8*L#U!!QBOGK]F+PQ>_LN_&'6OV6HY'_X0_5$EU[X="1B181E_
M]+TY2>B1NPDC'9'(Z**^CNH^M<5\1_AS>^*_%WA3Q=I1BCNO#^JM*TLG!-O)
M&R2H,>H*\>U<]>FVXU([Q?X/='9A<3[.G4HS?N37W26L7ZWT]&SJM<TG3]>T
M>XT;5;2.XMKJ%HKB"5<K(C##*1W!!KX[_P""<^F7_P"RI^T7\4?^"?\`K=RW
M]DZ?=+XP^&[2/UTB]8K+`N>T4ZD8]6)K[.;[O3-?-7[6WAEO`_[4WP7_`&E=
M-A,;V^NS^%-;E&!YEEJ$>(PQ[A;A(R/3>:Y\;3490KQWB_P>C_1_([\GK^TI
M5\!-^[5BVO*</>B_GK'_`+>/I8$'H:*9"%`RIZ]:?7H'B(****`"G1]Z;3H^
M]`#J***`/P)_;@_X(;_M;_!SXJZQJGP%^&MYXV\'7M[)<:5+HS))=6L3L6$,
MD)8,2N<;ER"!GBN3_9;_`."*/[</Q]\>VVD>-_A/JG@70(YU_M/6?$L`@=8\
M\B*)COD;&<<;?4U_0U-`LI`/0'BE6)5.<5\A+@O*Y8CVEWRWOR]/^&/V*GXW
M<7T\J6$M!S2LJC3YM.KULWYV.+_9]^!O@S]G/X.Z!\%?A_IPMM(\/:>MK:H<
M$OC):1CW9F+,3W+&OXU/^"R`9?\`@J?\?588Q\4M7QG_`*^7K^V+ZU_%%_P6
M<4I_P57^/ZG_`**EJ_\`Z4O7UL(1IP48JR6B/R&M5JXBK*K4=Y2;;;W;>K;]
M6?U6_P#!#>2.+_@D=\`S(VW'PYL<Y_W*_)'_`(/4/VF/A!\0/&GP?_9S\%>)
MM.U/Q'X3&J:EXC2SN%D>P2Y6W2&&3:3L=O)=]IY`VGN*Y?QO^PA_P7<_:0_8
MX^!'BG]AWXM:R_PQD^#.CPV?AKP[XS.DR6TXA`G$J;D\TNV6#%CP<<8Y_+/]
MH3]FO]H_]CO]H"+PG^VW\&]>T_6%NTO-1TS7KAE;5(-^69+E2PD5\$>8K-SG
MN*HS/V(_X,H/V?OB%8>+?B_^TEJ&DW%OX;NM,L="T^ZD0A+NY65YI=A/WMBE
M`2.[XKY(_P"#MK_E,!KW_8H:3_Z*-?MY_P`&^_\`P45_89_:]_9@MO@W^RA\
M.;?X>ZCX%LXTUCX?F0-)`K<?:D?K.COG+GG=PW49_$/_`(.VO^4O^N_]BAI/
M_HIJ`/U7_P"#1WQ-IO@W_@CWK7B[7[L0V&E>-M8N[R9CQ%#'#$[M^"@FOYS_
M`-N_]JWQ?^VS^USXY_::\:7TLUQXI\03W-K%(Q/V:T#E;>!?0)$$7\">]?N7
M_P`$+=4U+1O^#8SX]ZCI#,MS%IOC`Q%#@@_V<!_(U_/-X7MX+SQ/86MSCRY;
MV)7SZ%P#^E`']C7_``04_8D\(_L4_P#!,WX:>&[+0(K?Q%XI\/6OB3Q==&,"
M6:]O(EGV.>N(XW2,#ML/J:^SJP_AG8V>F?#G0-.T]56"WT6UB@"C`"+$H7'X
M`5N4`?FI_P`'2W[%'AK]J#_@F=K_`,48=!BD\4?"^0:YH]\L695MP0MS%GKM
M:/G'3*`]J_G?_P""+W[9/B']A_\`X*,?#GXOZ;J$L>G7&MQZ1XAMU?:MQ873
M"*5&]<9##/0J#7]<'_!1_3=.U?\`8'^,.G:LBM;R?#O51('&1Q;.1^H%?Q#^
M";JXL_&VDWEJ2)8M4@>/']X2*1^M`']\%M<0W5NES;R!XY$#(ZGA@1D&GURW
MP.NKF_\`@OX1OKH$RS>&+"24GKN-M&3^M=3SW%`'@'_!5H[?^"8_[0AQ_P`T
M5\3_`/IKN*_ER_X-KC_QNJ^"G_84U+_TV7=?U&_\%6_^48W[0G/_`#17Q/\`
M^FNXK^7'_@VQVC_@M1\%MYP!J>I$G_N&7=`']>&H_$WX<:+>OI>L^/M%L[F+
M`DM[K5(HW7ZJS`BK6A>-?!_BAWC\,^*M.U%HQF06-['-M^NPG%?R-?\`!6KX
M`?#O]I'_`(+%>*/@S_P3X\8Z_P#$K5O&'BN7[>\DOGQ+JLTS-/#!,"=UO#D@
MR'Y5"D`X7-?N+_P16_X($>$O^"35]<?M$^/?CGJ&N>,;[PN;?7;:,B'2[`$"
M24J,YDVX(#-C@$XH`_2S4=3TW1[.34=6OX;6WA4M-/<2!$11U)8\`?6OE[]J
MS]L']B'XC^#F^&ND?MI_"*/Q':ZW8W=C977Q&TV.19X+E'VD&;(;Y2,=<U_/
M-_P7!_X+8?M!?\%,OVF=0_9T^`_B?5=.^%MCK7]D^&]`TNX:-O$,WF"(7-QM
M(,F]_N1GY54C.3S7T/JO_!GQXM\,?L.:A\=/&'[3$=K\1-/\-2:Q<>'C8#^S
MH0D)E:W:8G?O`!&[&,]JF<(U(N+V9I1JRH58U([IW/Z)-.\6^&KG0$\31>)+
M"73G@$JZA%=HT!3`^82`[2OOFJ7_``N'X2_]%0\._P#@Z@_^+K^._P#X)U_M
M+?%SQUK]O_P3&^)'QF\3Q_"?XKZY9Z/J>F6%ZTO]F7)N%,5U;*20H$@7?&,+
M(I((S@CS7_@H]^Q3X]_X)X_M?>*?V6?'-_-=-H-X#8:GY907]G(`\,X'^TI'
MT.132L9G]M^E^)O#NN6']J:'K=I>6V2//M+A9$XZ\J2*RY/B]\*(7:*;XF>'
MT="0R/K,`*D=01OXKX%_X(%?L+_!#X>?\$G(=)^%OQF\0^(-(^,.CR:AJU^]
MSY4FG37%MY$T-N%)\HH0>>NX9K\!/VFO^"7^B:9_P6(3_@F3^S#\4-2\6-?^
M*K/2&UO4(0)+627#W#R;#AEAC+.S>B&F!_7]JGQ%^'^A^'?^$PUKQMI-II(&
M3JEUJ,4=L.<?ZQF"_K5_0=?T3Q)I\6L>'=7MKZSN$#P75I.LD<BGH5920P]Q
M7Y6ZK_P3D'_!.KX+_#[]G3PO\3KW4O#>F3":S\8^,)"-.TZ_DN"]TTQ`*VJM
M&$5&XXW`-DD'ZS_X);Z9KD'@S4]6MK2ZBT.YTG2D>66!8X+W64A==0NK9454
M:)W\O]X@"2$%AR2:`/JVBBB@".BBB@`/2OXH_P#@M`P;_@JW\?R#_P`U2U?_
M`-*'K^PO]M+]IO2OV-_V7O&?[3&M^$=1UVU\(:.]_+I6EKF:X"D#:/3KR>P!
M-?Q2_MF?M`R_M6?M5>/_`-I&;P[_`&2WC;Q5>:Q_9OF^9]F\^5G$>[`SC.,X
MH`_L$_X(D,K_`/!)WX"NN,?\*XT__P!%BOD'_@\.^!?@?QS_`,$P+3XUZEI5
MN/$'@?QUIQTO4#&/-%O=[[>>`-UVL6B<CUA!K!_X(K_\%^O^":/PS_X)S_#C
MX(?'/X_VG@[Q/X'\.1:5J>GZQ:3?O3%D"2-D1@P88/8C.*^(?^#ES_@O'\%O
M^"@G@/0_V0OV0M2NM2\':;K2:SXE\1S6[0KJ-S$CQP01*W)C7S'<D]6V8^[0
M!\Q_\&R7Q8\7?#'_`(+,_"2P\-7DJ6WB>XU#1=9@1B%N+66QG?:P[A9(XI/J
M@KN_^#MC'_#W[72.G_"(:3_Z*:O5?^#4K]@#Q%'^T'=?\%1/CG`OASX:_"[1
MK^73-:UD>3!=WDEO)#)*&?`\J&%Y69_[Q4=C7S9_P<C_`+4'P)_:Y_X*<:_\
M6?V>/B!:>)O#W]@Z?91ZM8AO)DEBC(<*6`)`)QG%`'Z]?\&M'PST[XT?\$./
M&WP@U8#[/XI\0>(=(F)[+<6J0D_^/U_-?\2O`'BGX-_$S6OAIXMLI+36O#>M
M7&G:C;N,-%<02M&X_!E-?T4_\&A'[:?[,F@?L<G]D'7OC!I-C\1+WQM?WEAX
M8O)3'<7<+QQL&BR,/PC'`.>.E>&_\'1G_!#SQY;_`!3U7_@HU^S#X)FU+2-:
M03?$/1=+MR\MI=*N#?+&HR4<`%\#A@6/4F@#]K/^"9W[1&A_M5_L"_"7X\Z)
M?I/_`&[X&T]K_8P/EWL<*PW,9]UGCD7\*]SK^5'_`(()_P#!PAKG_!,&TN?V
M>?C]X?O]?^%FH:BUW;BR.Z[T*X?`D>)6X>-L`LF1R,CDG/[,:W_P=,_\$>]*
M\"GQE:?'C4+V?R2Z:);>'Y_M9;'W"I`4'/O0!Z#_`,'!O[2VD?LR?\$H_BGX
MANM36"_\0:.=`T=-^&EN+H^6`OKA2S'V!K^3S]@GX`>)_P!J#]L?X=_`SPCI
MSW-YK_BVS@V*N=L0E#2.?0!%8D^@KZA_X+>?\%KOBG_P5[^*^E>&/"'AN]T#
MX;^';EO^$8\+"0R37MR_R_;+@+PTI7"J@R$!.,EC7ZD?\&LO_!$3QA^S);3_
M`+?W[4_A)].\6ZUIAMO`GAZ_AQ-I=I*/WMW(IY261<(HZJA;/+<`'E/_``7K
M_P"":'_!9?XT?MYMXU_8[T+QKK7P_M?">FV/AT^&_%OV.*Q$4"QRQ>69X]K%
MP6)`YSUKXAD_X(O_`/!Q%*YD?X/?%$D]2?'JG_V[K^N,#`P**`/Y_/\`@G+^
MQ-_P4[_9*_X)N_MK7G[=>F>)]*T35?@3K,>@Z7XC\1?;2]RFG7ADE11+($^4
MJ"<C/X5^'OP+\3?&?P;\18_$?P!O]9M?$MO87OV>YT!7-U%;FUE6Y92@+*!;
MF7<P^ZNXY&,U_81_P7$_:5^!_P`"O^":OQD\+_%3XG:1H>J>,/A;X@TKPOIU
M_=!9M3O)=/FC2*%.K$LZCT&>37\P?_!"+XM_"3X'?\%6/A5\2?CGXJT[1O"E
MGJ%]%JVHZM_Q[1)-87,*^9D$;2TBJ<\<\T`?1'_!J_\`MM?LX?LG_MVW/AK]
MH#PSI]O=^/K1-(\.^-KUOFTJY9^(26X1)CA2WK@'@U_2!_P4K\2:OX9_X)[_
M`!F\1>&I&^UP?#;5FMWC/(S:N"1^!)K^:K_@X5_X))Z7^Q!\:;3]JG]EZ%+O
MX+?$B;^T?#EYI#^9;Z3<2CS?LZ.N0(F!WQ'/W3@?=K]%/^"%'_!<OX,_MC?L
MD7?[`/\`P4`^+&GZ;XMBT-_#UAKOB&[$8\1Z=-"8$#2OP;E58*2QR_#<G-`'
MX:_\$S_%W@GP3^WW\-/B)\4K:6YT/0?$J:KJ<,,1D>5+=6FVJO<DH,>]?H1^
MU/\`\%5_^"L'_!?KXD7_`.RI^Q!\+=8T#X>S3^3?:3H!9#+;EB`^I7O"HA'/
ME@@'IAJ^%_VK_P!FWXZ?\$EO^"@<_A+Q5H#1WO@[Q-'J?AF^FA)M=8L5E\R&
M9"1AXY(\*PYP2RGI7]"7["G_``<,_P#!%32/V=;37-/USPQ\'M5DB^T>(O!E
MEX9%F?MQ4&5T%K%LFW-T?J>_2@#G_P#@C+_P;#?"7]A?Q1H_[2W[4?B*'QG\
M2]-=;G2;"V3&FZ)/CB101F>5<\.<`$9`Z&O*?^#R3]@,>-?@GX1_;]\#Z.9-
M1\'W2Z%XR:&/YGTZ=B;>=L=HYR4)])QZ5G_%O_@Z@^-/[1_[</@7]FW_`()>
M_!.+7=`O?$$-KJM]X@TR22ZUB-I%#F%$8?9HE3<Q=LGN0`.?V,_::^`7A/\`
M:L_9L\6?`#XD:9'-IWB_PW/IU]"P#!#+&0&'NK88'L5!H`_`_P#X-J/^"QWA
MC]EW]BSXW_`[XT>)$CB^'?AN[\8>"X;J<`W"8"2VD>>K&=H2`.OFGTKJ_P#@
MTM_9K\3?M+_M7?%;_@J/\9[1KJ\6^N;/1KRX7._4+QS+=2*3_=C(C'H'(K\7
M/VA_V>/B)^S?^TKXG_9B\4Z=,FN:!XBFTB2$*0TY$FV,@=PXVL/K7]/'P?\`
M'7P]_P"""/\`P2+^'GP]U+P[#>>/-4TH70T;/EFZU6X42S/,1R$BW*K'K\N!
MUK#$XFCA*$JU5VC'5L[,OR_&9KC:>#PD'*I-V27];=6^B/TP=H/]4Z@Y'0CK
M4D+*3M0#&.<"OYU?%W_!;S_@I1XG\42^(K/]H!M(A>8O'I>EZ-:BWC&>%`DC
M9F'U8FOT#_X(S?\`!8#XG?M<>/)_V=?VA;*RG\1)I[W>EZ]86PA%W&A&])8Q
MP'`(.5P#SP*^?P'%F6YABE0BG%O:_4_0\_\`"/BOA[*I9A6Y)PBKR46VXKJ]
M4KVZV;/TKHIFY_[P_*BOIS\PU["4444`5M8T;2?$.ESZ)KFG0W=G=1&.YM;B
M,/'*A&"K*>&!'4&OS\_:A_X-??\`@D9^TUK5WXK7X(ZAX$U>\=I+B[\`ZT]E
M$[GJWV9Q)`O7^&-<U^AE%`'XKZ[_`,&5G[$,NIA]&_:P^(=G;N3LMKFULIG/
ML&"IG_OFO8OV9_\`@TO_`."4/P.\0P>)?'.F^*OB7=VC!Q:>*]<"68<$$%H+
M58]XX^Z[,I[@UU7_``55U_7]*_X+"_L&Z+IFN7=O9ZAXB\4"^M(+AECN`L-A
MM#J#AL9.,],U\8^$/VS?V@/V%_\`@M-^T#^TEXBU>]U/X$7GQ9@\$?$:TDN)
M)$T&2[B\VQU%4)Q&B2(Z$CC$C`\LI`!^TWC+]F_]GOQS^SYJO[+NL>!-*A\`
MZOH<NBWOAW3E%K;K9R(4:)!%M\OCH5P01FOSYF_X-&_^"-=U.7CTSQ\I<\1Q
M>.R0/89C)JI_P22_9S^%O_!0[]@?XI_"_P"/VLZ[K/AVX_:$U^^M)])\3W5I
M,5BNG,.RX@</Y>U_N@[2,<5YM_P0-_X)W?L^>./C7\7_`(R^)[OQE>ZW\'/C
MU?:7X&-QXYU!X+:UMR?*26$RE+C'?S`V>]`'U#^Q]_P;F?\`!++]B+X\Z-^T
M9\(?"GB.X\4>'9'DT>;Q#XM>YBM9F0H91&`@+!68#=D#.<9YK[SNFT>^LFBO
MVAD@E4JPDP5<=P<\$5_.]HGA7X(?%']N7]IUOVA?V._VB?B_-IGQ@O+?2+SX
M4^);NWM=,@ZF"18[J(;B>1P>.]?1?_!930_`'PI_X)6_LT^$O!/@'XC>%_!]
MW\3]+2_\(7^KW,GB&.RGD=Y[.202M*\Y#N`-Y.2`#TH`^F/VS?\`@VJ_X)2?
MMH>(KSQY<_"Z[\#>([Z0RWFK_#S4!9I<2L22\EL5>`L2<DJBL2>2:^7]*_X,
MK?V($UEYM1_:P^(=S9JW-G#:V4<BCT,FUOSVUQO_``3VMOAOXQ_X*M^!='_X
M)8>'_C1X/\-^#8[H?'K1_B?XCNGA,#I^XC%M=RO)O+<@CCH:@G_;%^/_`.P_
M_P`%VOVB?VE=1UF^U'X)6OQ&T7PK\2--:XDDCTB.^TZ!K:_5"=J+'+&02,??
M.>M`'Z!?L*_\&^W_``2]_83UV#QO\,/@P?$OBFS8&W\4>-;\ZC<V[#O$A"PP
ML/[R1AO>OMFWGLPYM;>1<H,%`?NBOS0_X(<?M$Z+X-_8K_:9_:"\<>,9+W1/
M#W[07B[4([^>],BBRCM;.5%1F)PI!X`X^;BOBW_@F+^VOX_^#G_!0SX>?MD?
M&/\`:&M-7\/?M=W^NZ?K_A;^VEE_X1>X6\#:46B#DP[T*`9`P'<=A0!_0"=1
ML`Q5KV(%3@@R#B@:C8$!A>1[6.%8,,$^E?C+_P`%Q_\`@FU^SC\/?VCO@'X\
M\(W7C6SO_C7^T):Z1X]$7CW41%=6D\;/)'%&)=MOD@8,8!':NZ_X*U?LY>`O
MV$/A)^R5\$_V=-4\0Z;H7_#56BF1+_Q)=7D\JS.[2(\TSL[H3_"210!]??\`
M!23_`()(?L2_\%/;7P_/^UGH^K^;X7,HTK4M%UUK&2-)<;T8X964D`\C(/0U
M\M0?\&AW_!'EE6XM[#XBR+]X,/&^5(^HAZ5F?$CX5_\`#VG_`(+/?%#]E3]I
M'XB>*+3X4_!+PKITNF>!/#OB"?38]7OKL$M=3O`RR.%YQ@CMSC(.G^P?8>*_
MV#/^"M'Q+_X)C>!?BAXB\1_"F]^&2^+O#&E>)=6DOI_#LY;8\$<TA+^6V<@,
M2>.YY(!]N^-?V!OV1OB5^QQ;_L*^+_AU;W_PTL=`@TFRTJ2Z<O;00(%BD2?.
M]95P&$F<YSG.2*^-_!__``:7_P#!('PEXJT_QE8^&_'EY_9]W'<Q6EWXT=H)
M61@P#[(U8KD#(##-?G+_`,$V/VZ?CU^S?^P-\2/@E^TAXOOY_!7QJ^''BR_^
M$WBBZO9&:RUJTAGBGL3*QRK.$5U&>N,=:_1+6/VV=0_8Z_X-HOAU\:/[?9O%
M>M_!O1]'\.SW5P3+-J5Y;+$DFYCDLNYGSGJN:`/L?]L3_@G#^Q5_P4!^&5M\
M-/VE_@WIOB.QT^/R])OXY6AO=.(&,P7,9$B'`&1D@XY!K\\]2_X,Q?\`@FY?
M>)FU'3/C;\4[;3S+N.F+J=DY1<_=$AM\^V2":?\`\&\?Q;UK]F+]I;XA_P#!
M,3XD?M`6GC];W0=,\<^#?$$.L+=K++<6D0U&T5PS?ZN8$!<Y`B)_BKW#_@D+
MXL\4:_\`\%+?V\-&USQ'?7EII7Q0TB+3+:ZNGDCM$:"Z)6-6)"`D#@8Z4`>Z
M?L`_\$??V"O^":]C._[,WP9BMM;NX1'?^+=:N6O=4N4'\)FD_P!6O?9&$4GD
M@FO:_P!H3X[?#O\`9F^"WB3XZ_%37H=.T'POI,M_J%S,X`"(N0HSU9CA0.I)
M`KLZ_&+_`(.K/"/_``4]_::LO"/[*?[)O[//B7Q!\-9H5U;Q/J7AR'S6U"_5
MW6*VF`.5CC4>9M/#,X)^X*`/@;_@F)X;UO\`X+@_\'`,_P"U!\1O#48\,:-K
M<OB_6[18`(XK2T(6PMGP,$M*(0V>H5Z^A_\`@N9^U%%^T1^VQJ7AO0-3\_0_
M`]N-(LMCY0S*=T[#M]\[<_[-=A_P3<^"OBK_`((0?\$KO&?QH^-OA3^P_C=\
M7M0-EH.AWNW[39P(I2+>`>%C#23,/5E'<5\$:AJ%]JVH3ZKJEW)<7-U,TMQ/
M*V6DD8DLQ/<DDFOS_C7,U&$<'3>N\OT7ZG]#^!?"TZN+J9Y7C[L;PIWZM_$_
MDM/FR&OT<_X-O/@3XA\6_M2:Y\<VMW32O"VB/:><1\LEQ<$`)]0JDU^<L44L
M\J06\;/)(P6-$!)9B<``#J:_H[_X)&_LBR_L@?L<:!X0U_3A#XCUM/[7\1Y7
MYDN)@"(3_P!<TVK]0WK7S_"6`EC,TC4>U/5^O0_0O&/B.&3<*2PD6O:8CW$O
M[OVG]VGS/IS=_LC\J*?L_P!G]**_7^6)_&_+YA1113$%%%%`'S7^UA_P3X_X
M:>_;)^`7[6C?%`Z0WP/U'5;M=$&E^<-6^V)`NWS?,7R=OD==K9W=L5R/A/\`
MX)#?#;^UOVFX/BUXQ3Q1H'[26LI?:CHSZ2(3I`2%HU59/,;S&#,'#X0@J..]
M?85%`'RE_P`$G?\`@FS8_P#!*G]EV^_9TM/BY)XNMG\17FJQZK<:6+1XTE((
MC91(X8J!RV1GT%4/^"5O[,'PH_9LG^,.K?"W]HW3/B!'\0?B?>^);[^SK=(Q
MI,L^<VK;97WE?[QVY]*^M[J`7$;0N`5<;6!';O7Y4_MF?#+XQ_\`!(']J=OV
MXOV:='DU'X8>++\#Q[X4BR(89&;+Y`!$8;)9),?*_P`IX//G9AC:F`C&KRWA
M]JVZ7?Y=3W^'\GI9[7GA%4Y*S5Z:=N6<EO!OHVOAZ-Z'H.B_\$:OVXO@_P#'
M3XI?%W]E#_@J6_@"P^*?C*;Q#JNA_P#"J[74!%,_"J)9KC)VKQD!<^E=G^UY
M_P`$_P#QG\5?V7?A=IW[7O[;<=YJ?PB^(EGXPU_Q_<>$([9-56WN/,6%H(I0
MMN-I5-X+=,XKZ6_96_:Q^#O[7WPJL?BK\'O$D=Y9W$:BYM'8"XLIL?-#*F?E
M8'CT/49%>D:II.FZYITVDZO9175M<1F.>">,,DBD8((/!!KMA4C6I<U)IW6C
MZ'D5</5PF*='$P<91=I1>C5GJM>I\0ZQ^QE\%_VJ/VWO`_\`P4Q_8F_:HTG0
M_$>AVQT[QHFC6:7UKXKT[IY%RJ31E)%&0LA#'IP<"NL\-?\`!);X=R_$S]IW
MQ3\5_%Z>)M!_:4N;&34O#\FE"+^R%M[/[-A92[>:Q.)`VU=I`X/6N+_:`_X(
ML>'Y/&-S\8OV'?C-K'P?\632&:2VTJ1SIES(3GYHE(,>3W7(_P!FO(M:^-'_
M``<$?LCEM-\5_"C1?BGI5KQ'JVG6'VQI5'<^08YA_P`#3->14S3$8/3%47;^
M:/O)_+='UF'X8RW.(J668Z%W_P`NZS]E->5W[DODUZ'3?"/_`(-_]6^"O_!,
M?QO_`,$U?!7[7-U'IGCKX@2:YJOB9O#`\\:?(EJDE@(Q<8)9;8`R[NCGY>*Z
M7]I?_@W1_8*^*?[/%M\,?@%\-?#OPN\:Z9-87&B_$?1/#R27MO<6SHV]@'0R
M;]I##</O9SQ7A&J_\%^_VZ_"4C6'B[]@RVM+M!AQ/'J$7/\`NE#C\ZXKQ;_P
M7F_X*6^/@VG?#7]GC2M&DD^6-[3PW>7<J_3S#M)_X#7-/BK*H?S-]N5GJT?"
MCBZJU=4HKNZL+?@V?>W[:_[`-Q^TIH'P$\0?$_\`:$M](N?@9XZL/%6J:O-I
M`\O6I+:#RW4AI@+;><MNR^,]#7B__!2?XN?\$\/VX-5^%ND:K^WKX8\,3?";
MXK6'BZ1([?[8+][0M_HN0ZA-V?OC=C'0U\1>(OA/_P`%L_\`@H/>+:>-O#7C
MF[TV=L^5JO\`Q*M.0'OM?8A'L`37T;^R7_P;6F"^M?$_[87Q1BN(T8._A;PK
MN"M_LRW3@$CU"*/]ZN2.>9QCJML'A6H_S3NOZ_$]6?`W!N0X9SSO-%*ITA0M
M)^FS_%)>9Z9\1_V7_A;^WC^U?/\`MO\`_!+7_@H$?AW\5;+14TSQ7J6E:"FJ
MZ;K%GG]VEU;R,BEUQP<GH.,C->Q_L%?\$J[C]ECXB^-/VE_CO^T-JOQ8^,/Q
M`M%M->\;ZIIJ6<4%HH^2VMK9&811@\XW<X'2OH_X+?`7X2?L]^#[?P%\&_`U
MAH.E6R@):V4`7<1QN8]6/N2378U]50]M[)>UMS=;;'Y7C'@WBI?55)4^G-;F
MMYVLC\ZM0_X-[OA;XK_X)1V?_!-+Q]\76U"]T75[K5/#GQ!AT`1S:?=37#2[
MA!YIW+M8HR^8-P.>,5O^._\`@A_H/Q<^#W[-/[-_Q=^-$6O?#SX!Z=;Q:UX7
MG\.XB\73P6XAC>4F<B%!@G9A\YZU][45J<I\-^*O^"&7[.7@[]J/X5_M5?L7
MV6A_!W6?A[JLTNLV7A_PVK0>([*9`KVTP65-IXX?YL9/!S7)ZC_P1T_;2\`_
MM6_%[]I?]DO_`(*</\-XOC!XDBU?7-#'PPMM2"/$C+$OFSW'.T._(5<YY'%?
MHA1D>M`'%?L\^!_BM\-_A!HO@SXW?%X^//%%C;;-6\6'2([#^T)-Q/F>1&Q6
M/@@8!/2IOC?\9OA[^S]\--5^+/Q.UZ#3=&TFU::ZN9F`S@<*H_B8G@`=2:K_
M`!__`&A/A+^S3\.+WXI?&/Q=:Z1I%C&6>6>0;I6[1QKU=ST`'-?@1_P4Z_X*
MA_$;]OOQO_8^F_:-&^'^E71;1-!\SYIV'`N)\?><CHO10>.<D^#GF>X?)Z#U
MO4>R_5^1][P+P%F7&>8)13CAXOWY]EVCWD_PW9Q?_!1#]N7QK^W?\?+SXDZT
MTUKH5D6MO"^C/)D6EJ#P2.F]_O,??':O!:!7T!_P3S_8`^)G[>_QFM?!7AV"
M:P\-64J2^*/$1B)CL[?.2J=FE89"KZG)X!K\C_VO-<;UE.;/[)ODO"&1:M4L
M/1C^"_.3^]OS9[__`,$+/^"==W^TC\9(/VCOB1HQ/@[P;>++8Q7$?R:EJ*D%
M%YX*1G#'W"CUK]W;:-8TPHQP.E<?\"?@E\//V>?A?I'PF^%V@Q:?HVCVBP6L
M"#EL=78_Q,QY)[DUV4?&:_8LDRJ&48)4E\3U;[L_BGCCBW$\8Y[/&35J:TA'
MM'_-[L=1117L'QY'1110`4444`%%%%`!6+\0O`/A/XH^#M1^'_CG0;?4M(U:
MU>VU"RNHPR31L,$$&MJBIE%35GL5&4X24HNS6J:Z-'XJ?M-?LE_M<?\`!%_X
MS2_M*_LA:O>:K\-KVZW7UG(K2QVJ%O\`CWNXQU3LLPY'0D'K]V?L$_\`!8?]
MFS]M+3;3PY=:M'X3\;F("Z\,ZO.%$S]VMI3A9E]N&'<=Z^L?$'AW1?%&E3Z#
MX@TJ"]LKN)HKJUNH@\<J,,%64\$$5^4G_!0K_@@#J::E=_&?]A9Q;7B2-<R^
M#'NO*^<'=FSE)&QL]$8@>A%?*UL%F.2U'6P"YZ3U=/MYQ_R/U7!9QPYQM0C@
M^()>QQ25H8A;2[*JMG_BT]5U_6=)8I!N20$'N#FE*JP]:_!3]G+_`(+-?MV?
ML.^(?^%0?M`^';SQ'9:5)]GN=$\6Q20:C:A>"JS,-W;C<&!K]&_V:?\`@NU^
MP?\`'BVM]/\`%/CR7P)K,H`?3O%D?E1;_1+E<Q$?[Q4^U=F!XDRS&ODE+DGV
MEI^)X^>^&O%.2+VL:7MJ+U4Z?O)KO9:K[K>9]DW6EV%WS<6<<GLZ`_SIEOHF
MFVQW0:?!&?6.,+_*J7ACX@>"O&NFQ:SX/\5:=JMI.NZ*XTZ\29&'8@H2*UDD
M609%>ZE3FKJS/@Y>T@^65TT*$5>@I:0,I[TN0>AJR`HI-RYQFD>5$&<]*`'4
M9`ZFN:\=?&+X5?#+29-;^(WQ%T70K2)2TD^K:G%;JH'7EV%?&O[2_P#P<"?L
M/_!B*XTGX7ZM??$+5X\JL6@P,EF&']ZYE`5A[QAZXL5F.!P4;UJBCZO]-SV,
MKX?SO.ZBA@</.H_*+M\WLOFS[L>XAB&YY54#J6;&*^//V\O^"S/[,G[&MK=^
M$]&U>/QCXW"$0>'M'F#1V[=C<S#*Q#/\/+GL.]?E9^U[_P`%L_VQ?VI?M7A_
M1]?3P3X<FRG]E>'I&261#VDG^\W'7&![5\?SW%Q=S-<74[RR.Q9Y)&+,Q/4D
MGDFOBLTXTC9PP2_[>?Z+_,_=>$_`NM.<:^?3LM_9P>K\I2_-1^\]>_;$_;D^
M/W[;GCUO&7QD\4-);0NW]EZ':,4L[!#V1,\G&,L<DUX]6GX,\%>,/B+XBMO"
M/@+PQ?ZQJEY(([6PTZU::65CV"J":_3K_@GW_P`&]/B_Q#=67Q._;9E_LRQ7
M;+!X)L9PUQ+T(%S*I(0>J*2?4CI7Q^%P&9YWB.:"<F]Y/9?/]#]DS;B#A/@'
M+(TZCC2C%>[3BO>=NT>OFWIYGR/_`,$\_P#@F3\</V^/'<,>BV$NB^"K28?V
M[XLNXB(T0=8H`?\`72GH`.%ZL1P#^_7[+O[+'PE_9(^%MA\)?A!X=6RT^TC!
MGG(!FNY<?-+*W5F/Z=J[#X>?#;P/\*O"=GX&^'OABSTC2=/A$5I8V,`CCC4>
M@'\^];M?J>29#ALHI7^*H]Y?Y'\F\=>(.:<:XJTOW>'B_=IK\Y=Y?@NG<1%V
MKBGQ]Z;3H^]>^?`#J***`(Z*=Y?O1Y?O0`VBG>7[T>7[T`-HIWE^]'E^]`#:
M*=Y?O1Y?O0`VD*JW49I_E^]'E^]`'C7[5/["7[-'[8>AG2/C7\-++4+A8RMM
MJ\">5>6_ILE7YN/0Y'M7Y>_M6_\`!MY\8?!]Q=>(OV5?'MIXEL`2Z:%K;BWN
MT']U9?N/[9V_6OVG\OWI&A5A@_RKQ\PR++<SUK0][NM'_P`'YGV'#G'?$W"_
MNX*N_9_R2]Z'W/;Y6/Y@O$W@#]N+]B+Q"]MKNB>/OA]=(_$\)N+:WE([K)&?
M*D_`FO0_A]_P6<_X*-?#J!+6P_:$N]3BCP`FM6<5QP.V2H/ZU_1=K7A?0/$>
MGRZ3X@TBVOK69=LMM=VZR1N/0JP(-?/7Q;_X)$_\$^OC-))=^)?V=='L;J0D
MM=Z"K6+Y/?$1"Y_X#7S-7A/,L,[X+$M+LVU^6GX'ZCAO%_AS-;1S[*HR?645
M&7X22:_\"/RJ\/\`_!Q;^WKI4835[3PEJ)`Y:72#&?\`QUJV#_P<F?MH^45_
MX5WX*W8X?[--_+?7USX]_P"#;#]CC7)7E\%?$#Q?H98';&;F.X1?^^E!_6O.
MKW_@V%\!F3&F_M/ZN$R?]=HL9/Z-7+4R_C.E91J<WI)?K8]>CQ#X%XE<T\*H
M/LZ<_P#VVZ/FSQ3_`,'$?[?VMH8M%D\*Z2"N,V^C^80?7YVKQ[XC_P#!7#_@
MH9\3H9+;6?VD]8LX9!\T&D*EJOT!1<C\Z^[_`/B&$\)?]'0ZE_X(T_\`BJL6
M'_!L+\//,']I_M.:RR!LGR-&B!(_%JY*F6<95])2E_X$OT9Z>%XK\$L![U"E
M"Z_Z<R;^]Q;_`!/R/\7>//''Q`U`ZKX[\9:IK-R3DW&JZA)<-GZN3BLGEN.M
M?N?X"_X-MOV*]!D2;QEXS\7ZZ4(+(;V.W1O8A%S^M?0_P@_X)1_L"_!.2*[\
M'_LXZ#/=PX*7FLP&^DR._P"^+`'Z`4J7!F;5Y7K3BO.[?]?>;XOQPX1P%/DP
M5"<[;)14(_B_T/Y[_@C^R)^TU^T=J"6'P5^"7B'7E=]IO+73G6UC_P!Z=\1K
M^+5]_?LK_P#!MI\2_$D]MXB_:L^)5KH=J=KOH/AYO.N&'=7F(VKZ?*#]:_8_
M3?#VCZ/91Z=I.GPVMO",106\*HB#T``P*M+`B'*\5]'@>"\NP]I5VYO[D?FF
M?>-W%&9IT\%&.'@^J]Z7WM67R1XW^R]^PC^S-^R!H?\`9'P3^&-A87#1[;C5
MYHQ+>7'^_*WS8]A@>U>PQIL[`<#I4GE^]'E^]?6TJ5*A!0IQ22Z(_(,5B\5C
M:[KXB;G-[N3;;^;&T4[R_>CR_>M#G&TZ/O1Y?O2JNWO0`M%%%`!1110`4444
M`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`
*4444`%%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
